Item 5.07 Submission of Matters to a Vote of Security Holders.

On December 29, 2022, Pressure BioSciences, Inc. (the "Company") held a special meeting in lieu of the annual meeting of stockholders (the "Meeting"). At the Meeting, the stockholders voted on the following proposals described in detail in the Company's definitive proxy statement for the Meeting filed with the Securities and Exchange Commission on December 6, 2022. As of the record date for the Meeting, there were 11,128,187 shares of the Company's common stock, par value $0.01 per share, issued and outstanding and entitled to one vote for each share held. The holders of 60.59% of the Company's shares of common stock outstanding (6,742,402) submitted votes by proxy or in person at the Meeting, constituting a quorum.

Proposal 1 - Elect two directors as Class II Directors until the 2025 Annual Meeting of Stockholders. The election of the directors was approved as follows:





                                                   Shares voted
Nominee                 For          Against         Withhold         Broker Non-Votes
Vito J. Mangiardi     4,967,267           N/A            173,000              1,602,135
Kevin A. Pollack      5,007,054           N/A            133,213              1,602,135

Proposal 2 - Ratify the appointment of MaloneBailey LLP as the Company's independent auditor for fiscal year 2022. The ratification of the appointment of MaloneBailey LLP as the Company's independent auditor for fiscal year 2022 was approved as follows:





                    Shares voted
For                     6,600,688
Against                    97,770
Abstain                    43,944
Broker Non-Votes                0

© Edgar Online, source Glimpses